Neuropace Inc (NPCE) — Institutional Holders Breakdown (Q2 2026)

NPCE ranks #4275 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

115 institutions disclose a position in NPCE, but none treat it as a major bet — even First Light Asset Management, LLC, its most concentrated holder, allocates just 2.8% of its own portfolio to it.

First Light Asset Management, LLC has added to its NPCE position for two straight quarters, increasing it by $24.6M to reach $45.5M today.

Orbimed Advisors LLC has trimmed its NPCE position for two straight quarters, cutting it by $13.2M while still holding $23.9M.

NPCE is up 0.6% today, and institutions have been net buyers of $10.5M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

NPCE reported a net loss of $19.1M over the trailing twelve months.

• Not yet profitable — net loss of $19.1M over the trailing twelve months
• Revenue grew 16.9% year over year
• Net income improved year over year, from -$25.9M to -$19.1M
• Operating cash flow was negative, using $11.0M in cash
• Current ratio of 5.28x — enough short-term assets to cover short-term liabilities
• Liabilities run 4.55x equity — a highly leveraged balance sheet worth noting